Literature DB >> 6167357

Cytokinetics of tumour and endothelial cells and vascularization of lung metastases in C3H/He mice.

N Gunduz.   

Abstract

A model of lung metastases was developed using intravenous injection of tumour cell aggregates of spontaneous C3H/He mammary tumours in syngeneic mice. The growth rate of lung tumours decreased with increasing tumour volume with mean host survival of 46 days. The cytokinetics of individual tumours ranging between 0.004 and 4.2 mm3 in volume were studied. The labelling index (LI) ranged between 12 and 17%, the DNA synthesis time (Ts) being 9-10 hr. The growth fraction (GF) ranged between 26 and 38%. The cell cycle time (Tc) was found to be 18-19 hr. The LI and the GF decreased with increasing tumour volume doubling time (Td). No correlation was found between the tumour volume and Tc. The LI of endothelial cells within these tumours, ranging between 0.004 and 4.2 mm3 in volume was 14-15% and endothelial cell proliferation was not affected by tumour growth. Vascular parameters were also determined for these tumours as a function of tumour volume. Vascular volume increased with increasing tumour size while the percentage of capillary vessels decreased. The cellular volume to capillary volume ratio increased with increasing tumour volume. Necrosis was observed in 0.27 mm3 tumours and increased with increasing tumour size. The results from these studies suggested that the age-dependent decrease in proliferative activity of tumour cells growing in the lung is related to change in effective vascularity.

Entities:  

Mesh:

Year:  1981        PMID: 6167357     DOI: 10.1111/j.1365-2184.1981.tb00542.x

Source DB:  PubMed          Journal:  Cell Tissue Kinet        ISSN: 0008-8730


  10 in total

1.  Proliferative potential of vascular components in human glioblastoma multiforme.

Authors:  T Nagashima; T Hoshino; K G Cho
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

2.  Growth of metastases of the mouse adenocarcinoma EO 771: an allometric relationship between growth of the primary tumors and their metastases.

Authors:  I D Bassukas; B Maurer-Schultze
Journal:  Clin Exp Metastasis       Date:  1990 Jul-Aug       Impact factor: 5.150

3.  Mechanism of growth retardation of the adenocarcinoma EO 771.

Authors:  I D Bassukas; B Maurer-Schultze
Journal:  Radiat Environ Biophys       Date:  1987       Impact factor: 1.925

4.  Dynamic heterogeneity: isolation of murine tumor cell populations enriched for metastatic variants and quantification of the unstable expression of the phenotype.

Authors:  S D Young; R P Hill
Journal:  Clin Exp Metastasis       Date:  1986 Jul-Sep       Impact factor: 5.150

5.  Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma.

Authors:  R K Vartanian; N Weidner
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

6.  Angiogenesis in Endocrine Neoplasms.

Authors:  Martin Jugenburg; Kalman Kovacs; Ivan Jugenburg; Bernd W. Scheithauer
Journal:  Endocr Pathol       Date:  1997       Impact factor: 4.056

7.  Endothelial proliferation in tumours and normal tissues: continuous labelling studies.

Authors:  B Hobson; J Denekamp
Journal:  Br J Cancer       Date:  1984-04       Impact factor: 7.640

Review 8.  Tumour vasculature--a potential therapeutic target.

Authors:  C T Baillie; M C Winslet; N J Bradley
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

9.  Clonal variation in the sensitivity of a murine mammary carcinoma to melphalan.

Authors:  T J McMillan; T C Stephens; G G Steel
Journal:  Br J Cancer       Date:  1986-06       Impact factor: 7.640

10.  Endothelial-cell proliferation in experimental tumours.

Authors:  J Denekamp; B Hobson
Journal:  Br J Cancer       Date:  1982-11       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.